RESCON Summit · Inhalation & Respiratory Drug Delivery · Connected Devices
RESCON Summit USA 2027 · New Jersey, USA

From device engineering to commercial manufacturing.

A focused meeting place for the people developing, engineering and producing the next generation of inhalation and respiratory drug-delivery technologies.

28–29 Sept 2027New Jersey, USA
Two full daysScientific programme & networking
100+ professionalsTargeted industry community
RESCON / USA2027 EDITION

The inhalation
value chain.

01Design the delivery platform
02Qualify materials & components
03Manufacture at commercial scale
04Validate performance & delivery

Inhalation & respiratory drug delivery · Connected devices

The Summit

Real technical challenges. Meaningful industry connections.

RESCON Summit USA 2027 brings together pharmaceutical and biotechnology companies, device developers, manufacturing specialists, materials suppliers, technology providers and regulatory experts on September 28–29, 2027 in New Jersey, USA.

Moving beyond scientific discovery alone, the programme examines the decisions that make respiratory products work in practice: inhaler platform design, precision components, material qualification, biological safety, formulation–device compatibility, process development and commercial-scale manufacturing.

Through practical presentations, two industry panels and structured networking, RESCON connects those defining product requirements with the specialists designing the technologies and processes that meet them.

01 / PLATFORM

Design

Device performance and reliability

02 / MATERIALS

Qualify

Safety, compatibility and testing

03 / PRODUCTION

Scale

Manufacturing and industrialisation

04 / DELIVERY

Validate

Aerosol quality and patient use

Two days, one connected programme

From technical concept to industrial reality.

The preliminary scientific programme balances device and component engineering with manufacturing, regulatory strategy and emerging drug-delivery approaches.

Day 01 · Engineering & MaterialsTue · 28 Sept

Design, materials & sustainable inhalation

Examine the technical foundations of robust inhalation products, with hands-on engineering, materials qualification and low-GWP transition.

  • DPI, pMDI, soft-mist and nebulizer platform engineering
  • Polymers, moulding, valves, actuators and component performance
  • Extractables & leachables, biocompatibility and ISO 18562
  • Sustainable pMDIs, low-GWP propellants and production readiness
  • Industry panel on engineering sustainable inhalation products
Day 02 · Manufacturing & DeliveryWed · 29 Sept

Connected devices, industrial scale-up & complex medicines

Follow the journey through drug–device integration, regulatory expectations, precision production and delivery performance.

  • Nebulizer systems, smart inhalers and human factors
  • FDA expectations for respiratory combination products
  • Automation, QbD, spray drying and aerosol performance testing
  • mRNA/LNP and biologics delivery compatibility and stability
  • Industry panel on commercialisation and supply-chain decisions
Scientific focus · RESCON USA 2027

The technologies and challenges shaping inhalation.

Explore the key topics across the full inhalation-device, respiratory-delivery and manufacturing value chain.

01 / SCIENTIFIC FOCUS

Device engineering & platforms

DPI, pMDI, soft-mist and nebulizer design, dose-control mechanisms and reliable performance.

02 / SCIENTIFIC FOCUS

Materials & precision components

Polymers, plastics, elastomers, injection moulding, tooling and high-precision assembly.

03 / SCIENTIFIC FOCUS

E&L & biocompatibility

Chemical characterization, ISO 10993 / ISO 18562, material compatibility and product safety.

04 / SCIENTIFIC FOCUS

Sustainable inhalation

Low-GWP propellants, valve and canister compatibility, reformulation and scale-up readiness.

05 / SCIENTIFIC FOCUS

Smart & connected systems

Nebulization, connected inhalers, adherence technology, usability and human factors.

06 / SCIENTIFIC FOCUS

Combination products & FDA

Respiratory drug–device design controls, risk management, submissions and lifecycle strategy.

07 / SCIENTIFIC FOCUS

Manufacturing & analytical testing

Design transfer, dry-powder dosing, automation, QbD, cascade impaction and performance methods.

08 / SCIENTIFIC FOCUS

Advanced aerosol therapeutics

Inhaled biologics, mRNA/LNP stability, device compatibility, spray drying and lung-deposition modelling.

Who attends RESCON?

The people who develop, specify and supply inhalation technology.

RESCON is designed for senior technical professionals and decision-makers across pharmaceutical product ownership, device engineering, manufacturing and the supporting technology ecosystem.

01 / PHARMA & BIOTECH

Drug product teams

Respiratory R&D, CMC, formulation science, combination-product development and technical operations.

02 / DEVICE DEVELOPMENT

Engineering leaders

Device design, human factors, systems engineering, product development and technical programme leadership.

03 / INDUSTRIAL SUPPLY

Materials & manufacturing

Polymers, components, precision tooling, automation, contract manufacturing and process scale-up.

04 / TECHNICAL ASSURANCE

Quality & regulatory

Analytical development, aerosol testing, E&L, biocompatibility, regulatory science and quality assurance.

The summit also welcomes academic researchers, consultants and business development professionals working on respiratory technology partnerships.

The RESCON Experience

Technical exchange. Personal connections.

Focused sessions and networking designed to help participants exchange ideas, assess technologies and build collaborations.

A presentation at an earlier RESCON Summit
Expertise & exchange

Practical science, in the room with industry.

Presentations, industry panels and conversations that continue beyond the stage.

The RESCON community

See the summit in action.

Discover the atmosphere and technical conversations at the previous RESCON Summit in San Francisco.

Watch the 2025 event trailer
Networking at an earlier RESCON SummitMeaningful networking
across the industry.

Photographs are from previous RESCON editions and illustrate the conference experience, not the future New Jersey venue.